H.R. 6624 · 119th Congress · International Affairs

Biological Intellectual Property Protection Act of 2025

Protects intellectual property rights related to biological materials and organisms. AI-read

In committee754 words Introduced Dec 11, 2025 · Latest action Apr 22, 2026

How far it has goneStage 2 of 6
  1. IntroducedDec 11, 2025 Done
  2. CommitteeReferred to Foreign Affairs Current stage
  3. House floorNot yet Not reached yet
  4. Senate floorNot yet Not reached yet
  5. Chambers agreeNot yet Not reached yet
  6. PresidentNot yet Not reached yet

What it does

The Congressional Research Service hasn’t published a summary of this bill. Read the full text on Congress.gov.

Who lobbies on it

2 organizations, more than 78% of House bills · 5 filings · Q4 2025–Q3 2026

See which of this bill’s sponsors and cosponsors got money from the lobbying organizations’ PACs → Pro

One square per quarter since introduction, oldest left. Filled = named H.R. 6624 or S. 3452 that quarter.

  1. Amgen Inc 3 of 4 quarters
    “…S. 3452/HR 6624 Biological Intellectual Property Protection Act of 2025”

    $8.2M lobbying spend in 2026 to date, all issuesQ3 2026 filing · names both

  2. Pharmaceutical Research and Manufacturers of America 2 of 4 quarters
    “Proclamation: Adjusting Imports of Pharmaceuticals and Pharmaceutical Ingredients Into the United States (April 2, 2026) S. 2296: BIOSECURE Act (S.Amdt. 3236 to National Defense Authorization Act for FY 2026) S. 3452: Biological Intellectual Property Protection Act of 2025 S. 5043: Secure Drug Supply Chain Act of 2026…”

    $26.6M lobbying spend in 2026 to date, all issuesQ3 2026 filing · names both

Organizations that named H.R. 6624 or its companion S. 3452 in a quarterly lobbying report. Covers organizations with a PAC on file; reports from organizations without one aren’t loaded yet. Spend is the organization’s total across all issues: reports don’t split spending by bill. Reports naming only S. 3452 are included and tagged. “Gave to” means the organization’s PAC gave to the member’s campaign in the 2025–26 cycle, net of refunds; it doesn’t mean the money was about this bill. Members sponsoring the companion, S. 3452, are counted on that bill’s page, not here. Organizations may lobby for, against, or to change a bill; filings don’t say which. Source: Senate lobbying disclosures (LD-2) from lda.gov; PAC gifts from FEC filings; quotes are word for word from the “specific lobbying issues” field; where a filing lists many bills, the quote starts where it names this one.

Actions

4 actions · newest first
  1. Apr 22, 2026Ordered to be Reported in the Nature of a Substitute (Amended) by the Yeas and Nays: 30 - 14.
  2. Apr 22, 2026Committee Consideration and Mark-up Session Held
  3. Dec 11, 2025Referred to the House Committee on Foreign Affairs.
  4. Dec 11, 2025Introduced in House